Format

Send to

Choose Destination
Br J Haematol. 2018 Feb 7. doi: 10.1111/bjh.15123. [Epub ahead of print]

Follow-up of a randomised phase II study of chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: impact on allogeneic haematopoietic stem cell transplantation.

Author information

1
Department of Haematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
2
Department of Haematology, Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki, Japan.
3
Department of Haematology and Institute for Clinical Research, National Hospital Organization Kumamoto Medical Centre, Kumamoto, Japan.
4
Department of Haematology, Kumamoto Shinto General Hospital, Kumamoto, Japan.
5
Department of Haematology, National Hospital Organization Kyushu Cancer Centre Hospital, Fukuoka, Japan.
6
Department of Haematology and Immunology, Kagoshima University Hospital, Kagoshima, Japan.
7
Department of Haematology, Oita Prefectural Hospital, Oita, Japan.
8
Department of Haematology, Rheumatology and Infectious Disease, Kumamoto University Hospital, Kumamoto, Japan.
9
Department of Haematology, Imamura General Hospital, Kagoshima, Japan.
10
Department of Haematology, National Cancer Centre Hospital, Tokyo, Japan.
11
Department of Haematology and Cell Therapy, Aichi Cancer Centre Hospital, Nagoya, Aichi, Japan.
12
Department of Haematology, Clinical Immunology and Infectious Disease, Ehime University Graduate School of Medicine, Ehime, Japan.
13
Division of Medical Oncology, Haematology, and Infectious Diseases, Department of Medicine, Fukuoka University Hospital, Fukuoka, Japan.
14
Department of Haematology, National Hospital Organization Nagasaki Medical Centre, Omura, Nagasaki, Japan.
15
Department of Internal Medicine, Heartlife Hospital, Okinawa, Japan.
16
Department of Haematology, Kokura Memorial Hospital, Kitakyushu, Fukuoka, Japan.
17
Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
18
Department of Haematology, Sasebo City General Hospital, Sasebo, Nagasaki, Japan.
19
Innovative Clinical Research Centre, Kanazawa University, Kanazawa, Japan.
20
Medical Affairs, Kyowa Hakko Kirin Co., Ltd., Tokyo, Japan.
21
Department of Tumor Immunology, Aichi Medical University School of Medicine, Nagoya, Aichi, Japan.

KEYWORDS:

adult T-cell leukaemia-lymphoma; follow-up; mogamulizumab

PMID:
29411857
DOI:
10.1111/bjh.15123

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center